Coastlands Capital LP reports Adial Pharmaceuticals common share purchase worth $32,613.87

• Coastlands Capital, a 10% owner of Adial Pharmaceuticals, increased its stake to 385,075 common shares.
• The purchases totaled 11,753 shares at prices ranging from USD 2.7 to USD 2.79.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Adial Pharmaceuticals Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001104659-26-082972), on July 13, 2026, and is solely responsible for the information contained therein.